Palisade bio (nasdaq: pali) to present at the biocom global life science partnering conference

Carlsbad, calif., feb. 18, 2022 (globe newswire) -- palisade bio, inc. (nasdaq: pali), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (gi) complications, will present at the biocom global life science partnering conference in san diego on thursday, february 24, 2022. palisade bio's chief executive officer, tom hallam, ph.d., is scheduled to present an updated presentation at 11:30 a.m. pacific time. palisade bio's presentation can be accessed at on our website at www.palisadebio.com/investors.
PALI Ratings Summary
PALI Quant Ranking